Zai Lab Announces Participation in February Investor Conferences
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) announced its participation in several investor conferences in February 2023.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) announced its participation in several investor conferences in February 2023. Key events include a fireside chat at the Guggenheim Oncology Conference on February 8, and two chats on February 14 at the SVB Securities Global Biopharma Conference and the Citi Biotech C-Suite Fireside Chat Series. Interested parties can access the webcast links in the Investor Relations section of Zai Lab's website. The company aims to deliver transformative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders globally.
Positive
- Participation in multiple significant investor conferences in February 2023.
- Increased visibility and engagement with investors, which may positively influence the stock price.
Negative
- None.
Details
News Market Reaction – ZLAB
The recorded move for ZLAB in the trading session of this news was -1.50%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SHANGHAI and CAMBRIDGE, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), today announced that members of the company’s senior management team will participate in the following investor conferences in February 2023:
Guggenheim Oncology Conference
Fireside Chat: Wednesday, February 8, 2023, 3:20 p.m. EST
Location: New York
SVB Securities Global Biopharma Conference
Fireside Chat: Tuesday, February 14, 2023, 8:00 a.m. EST
Citi Biotech C-Suite Fireside Chat Series
Fireside Chat: Tuesday, February 14, 2023, 11:00 a.m. EST
Webcast links of the presentations will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab’s website. The archived replay will be viewable after each of the events for 90 days.
About Zai Lab
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States focused on bringing transformative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders to patients in China and around the world. Our goal is to leverage our competencies and resources to positively impact human health worldwide.
For additional information about Zai Lab, including our products, business activities and partnerships, research, and other events or developments, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.
For more information, please contact:
Investor Relations: Lina Zhang
+86 136 8257 6943
lina.zhang@zailaboratory.com
Media: Christine Drury / Xiaoyu Chen
+1 (317) 385-9227 / +86 185 0015 5011
christine.drury@zailaboratory.com / xiaoyu.chen@zailaboratory.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.